Chemical and Biological Defense Program - EMD

Abstract

This program element (PE) resources System Development & Demonstration across the Understand, Protect, Mitigate, and Enabling Investments portfolios. The Chemical Biological Defense Programs (CBDP) investments provide an integrated, layered capability to enable Countering Weapons of Mass Destruction (CWMD) missions ranging from combat operations to Department of Defense (DoD) support to domestic incident prevention and response. The projects in this PE support the development, build, and test of products to verify that all operational and derived requirements have been met and to support production or deployment decisions. The activities include mature system development, integration, and demonstration to support Milestone C decisions, and conducting operational tests and evaluation of production representative articles. FY24 funding accelerates characterization and situational awareness of emerging biothreats and accelerates delivery of improved protection from and mitigation of biothreats, including rapid repurposing of available therapeutics and development of new vaccines. Individual Projects include: - Understand (UN5): Provides the Joint Force the ability to detect and identify hazards from traditional and emerging chemical and biological threats to improve the timeliness and confidence of information for decision-makers. Supports freedom of maneuver and informs commanders' decisions by predicting, locating, identifying, analyzing, and warning of chemical and biological (CB) hazards. - Protect (PT5): Provides the Joint Force the ability to prevent the effects of exposure to chemical and biological hazards. Protects personnel against chemical, biological, and radiological (CBR) liquid, vapor, and aerosol hazards through next-generation prototypes of masks, filters, and ensembles to reduce physiological, psychological, and logistical burdens to the Warfighter. Medical countermeasure efforts conducted during this phase include the development of a large-scale manufacturing process and validation of that process, nonclinical studies, demonstration of manufacturing consistency, and expanded clinical human safety studies. Focuses on platform-based approaches to accelerate the development of prophylactic medical countermeasures that rapidly and durably protect against Biological Warfare Agents (BWAs), toxins, non-traditional and emerging chemical threats with minimal doses. The results of these efforts will be used to submit a Biologics License Application (BLA) to the U.S. Food & Drug Administration (FDA) for product licensure. - Mitigate (MT5): Preserves combat power by mitigating exposure to CB hazards and restoring combat readiness of critical personnel and platforms. Enables Joint Force lethality by providing capabilities for Warfighters to rapidly respond to and mitigate the adverse effects of CB hazards. Fields mitigation capabilities against engineered biological agents, opioids and other Pharmaceutical-Based Agents, and Fourth Generation Agents (FGAs). - Enabling Investments (EN5): Provides fundamental knowledge and technology demonstrations as key portfolio enablers integral to responding to emerging threats. Dedicated funding for this Project supports National and Departmental incident response and preparedness regarding CB threats. - Contamination Avoidance (CA5), Collective Protection (CO5), Decontamination (DE5), Individual Protection (IP5), Medical Biological Defense (MB5) and Medical Chemical Defense (MC5) are no longer active FY24 Projects due to budget restructuring. Middle Tier Acquisition programs: The total cost of the Rapid Opioid Countermeasure System (ROCS) Middle Tier of Acquisition effort is $12.974 million, including RDT&E (Project MC5) and procurement of prototype units (CBDP BLIN Protection & Hazard Mitigation). The ROCS is fully funded across the Future Years Defense Program. The total cost of the Forward Area Mobility Spray System (FAMS-S) Middle Tier of Acquisition effort is $34.141 million, including RDT&E (Projects DE5 and MT5) and procurement of prototype units (CBDP BLIN Protection & Hazard Mitigation). The FAMS-S program is fully funded across the Future Years Defense Program. The total cost of the Uniform Integrated Protective Ensemble Family of Systems Gloves (UIPE FOS GLOVES) Middle Tier of Acquisition effort is $49.483 million, including RDT&E (Projects IP4 and PT5) and procurement of prototype units (CBDP BLIN Protection & Hazard Mitigation). The UIPE FOS GLOVES program is fully funded across the Future Years Defense Program. The projects in this PE support the engineering and manufacturing development phase of the Department of Defense (DoD) acquisition system and are, therefore, correctly placed in Budget Activity 5.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2024
Source ID
0604384BP_5_0400_PB_2024
Change Summary Explanation
Funding: FY 2022 (-$2.237 Million): Below threshold reprogramming to Advanced Component Development & Prototypes, Budget Activity 4 for Advanced Emerging Threat Defense efforts, and reprogrammed prior year execution balances to RDT&E Management Support, Budget Activity 6 in support of the Departments higher priorities. FY 2022 (-$6.488 Million): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY 2023 (-$10.537 Million): Congressional Directed Reductions. FY 2024 (+$106.772 Million): Increase provides for biological defense improvement efforts, Next Generation Diagnostic System Increment 2 Man Portable Diagnostic System continued development and testing, Alternate Autoinjector Manufacturer Capability design development and prototype evaluations, complete engineering and manufacturing development (EMD) activities for the Multi-Phase Chemical Agent Detector, Aerosol Vapor Chemical Agent Detector activities in support of a Full Rate Production decision, Botulinum Monoclonal Antibodies manufacturing and clinical studies, initiating efforts within the Understand, Protect and Mitigate portfolios, and Departmental inflation rate adjustments (+$1.687 Million). Schedule: N/A Technical: Provides for critical new start programs Advanced System for Protection and Integrated Reduction of Encumbrances - Enhanced Biodefense (ASPIRE-ENBD), Collective Protection CONEX Enhanced Biodefense (COL PRO CONEX-ENBD), Portable Patient Transport System-Enhanced Biodefense (PPTS-ENBD), and Shipboard Isolation System (SIS).
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical
  • Ground and Sea Platforms

DTIC Thesaurus Topics

  • Aircrafts
  • Biological Products
  • Chemical Warfare
  • Chemical Warfare Agents
  • Cognitive Systems Engineering
  • Detectors
  • Health Services
  • Medical Personnel
  • National Security
  • Personal Protective Equipment
  • Systems Engineering
  • Test And Evaluation
  • Therapy
  • Unmanned Aerial Systems
  • Unmanned Aerial Vehicles
  • Warfare
  • Warning Systems

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology

Related Documents